I analyze early-stage public and private biotechnology and pharmaceutical companies as part of our diligence process for potential investments.
Using organic synthesis and molecular biology techniques, I analyzed small molecule inhibitors aimed at bacterial virulence.
I measured the adsorption of nucleotide monophosphates to single-walled carbon nanotubes.